Conference Coverage
Latest News
Dealing with Hot Flashes? Try Hypnosis
Hypnosis can address the “perfect storm” of mental and physical issues that come with menopause symptoms.
Latest News
Elinzanetant Shows Significant Improvement in Menopausal Vasomotor and Sleep Symptoms
The women who are the best candidates for elinzanetant include those who have had an estrogen-sensitive cancer, such as breast or endometrial...
Latest News
Identifying Drug-Induced Rashes in Skin of Color: Heightened Awareness Can Accelerate Diagnosis
In patients with DIHS and many of the even more serious types of rashes traced to drug exposures, the delay to appearance of the rash from the...
Latest News
FDA Initiative Aims to Improve Diversity in Clinical Trials
This initiative could be a critical step toward ensuring diversity in major clinical trials after years of stagnation, Dr. Valerie Harvey said.
Latest News
Most Women With Genitourinary Syndrome of Menopause Do Not Receive Effective Treatment
“Clearly, there is underutilization of low-dose vaginal hormonal therapies, which are known to be safe and effective.”
Latest News
Hormone Therapy for Menopause Remains at Historic Lows Despite Effectiveness and Safety Profile
The lack of education among providers is likely the biggest reason for the decline.
Latest News
Laser, Radiofrequency Therapies Offer Little Benefit for Genitourinary Syndrome of Menopause
While not surprised to find little evidence of benefit, “we were a little bit surprised that we also didn’t find significant evidence of harms.”...
Latest News
NSAIDs Offer No Relief for Pain From IUD Placement
“We’re challenging the current practice of using just NSAIDs as a first-line of treatment.”
Conference Coverage
A Simple Blood Test May Predict Cancer Risk in T2D
Can the markers of inflammation IL-6, tumor necrosis factor alpha (TNF-alpha), and high-sensitivity C-reactive protein (hsCRP) be predictive...
Conference Coverage
Hormone Therapy Can Benefit Women into Their 80s
Analysis finds hot flashes were the top reason women continued hormone therapy after age 65 but many other reasons were reported.
Conference Coverage
Outcomes with CDK4/6 Inhibitors Vary in BC
A large Italian study found real-world differences in short-term outcomes among first line CDK4/6 inhibitors palbociclib, ribociclib and...